Concepedia

Author

Pascal Artru

Hôpital Privé Jean MermoORCID

Also Known As

Artru Pascal, Artru, P., Artru, Pascal, J Ezenfis, M Mabro, Mehdi Karoui, P Artru, P. Artru, Pascal ARTRU, Pascal Artru

262

Publications

10.3K

Citations

37

H-Index

58

Concepts

All Affiliations

Hôpital Privé Jean MermoSorbonne UniversitéAssistance Publique – Hôpitaux de ParisHôpital Saint-AntoineHôpital Européen Georges-Pompidou
PA

About

Pascal Artru is an author at Hôpital Privé Jean Mermo specializing in oncology, medicine, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

23

53

2.2K

2

Health Sciences

13

15

597

3

Biostatistics

3

3

140

4

Engineering

1

1

112

5

Public Health

1

1

75

Pascal Artru

×

87

Publications

9.8K

Citations

36

H-Index

YearCitations

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

Thierry Conroy, Pascal Hammel, Mohamed Hebbar,

New England Journal of Medicine

2018

2.7K

Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial

Thierry Conroy, Jean-François Bosset, Pierre-Luc Etienne,

The Lancet Oncology

2021

1.2K

Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib

Pascal Hammel, F. Huguet, Jean‐Luc Van Laethem,

JAMA

2016

1K

Impact of Chemoradiotherapy After Disease Control With Chemotherapy in Locally Advanced Pancreatic Adenocarcinoma in GERCOR Phase II and III Studies

F. Huguet, Thierry André, Pascal Hammel,

Journal of Clinical Oncology

2007

533

Can Chemotherapy Be Discontinued in Unresectable Metastatic Colorectal Cancer? The GERCOR OPTIMOX2 Study

Benoist Chibaudel, Frédérique Maindrault‐Gœbel, Gérard Lledo,

Journal of Clinical Oncology

2009

394

Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

Thierry Conroy, Florence Castan, Anthony Lopez,

JAMA Oncology

2022

284

Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial

François‐Clément Bidard, F. Huguet, Christophe Louvet,

Annals of Oncology

2013

187

RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: the AGEO RASANC prospective multicenter study

Jean‐Baptiste Bachet, Olivier Bouché, Olivier Dubreuil,

Annals of Oncology

2018

175

Efficacy of Adjuvant Chemotherapy in Colon Cancer With Microsatellite Instability: A Large Multicenter AGEO Study

David Tougeron, Guillaume Mouillet, Isabelle Trouilloud,

JNCI Journal of the National Cancer Institute

2016

156

High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7)

F. Maindrault-Gœbel, Aimery de Gramont, Christophe Louvet,

European Journal of Cancer

2001

147

Page 1